Trials and tribulations aside, if partnered with AMBS for a Diagnostics division, this will really take off. Most of AMBS diagnostics are already in CLIA approved laboratories, and have been utilized to detect PD and ALZ for other companies to conduct drug trials...only a matter of time before full blown commercialization and into the Testing Market for Hospitals and major Pharma companies...$500+ million market possibilities.
Buying into AVDX is buying into AMBS...look at their boards as well...up 30+% Great time to buy into both companies and possibly get a 10 Bagger!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.